Jose Bartelt-Hofer

Senior Project Lead (Rare Blood Disorders)
Sanofi Genzyme, Chilly-Mazarin, France

Presentation(s):

• OC 40.3 - Consumption of On-demand Factor Concentrates and Bypassing Agents for Management of Breakthrough Bleeds with Fitusiran Prophylaxis in People with Haemophilia A or B: An Analysis of Two Phase 3 Studies

  Monday, July 11, 2022
  3:15 PM – 3:30 PM